Net‐clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Net‐clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more

Published:2019-08-26 Issue:12 Volume:17 Page:2089-2098
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Ageno Walter¹,Lopes Renato D.²,Yee Megan K.³,Hernandez Adrian²,Hull Russell D.⁴,Goldhaber Samuel Z.⁵,Gibson C. Michael³,Cohen Alexander T.⁶

Affiliation:

1. Department of Medicine and Surgery University of Insubria Varese Italy

2. Duke University and Duke Clinical Research Institute Durham North Carolina

3. Boston Clinical Research Institute Newton Massachusetts

4. R.A.H Faculty of Medicine Division of Cardiology University of Calgary Calgary AB Canada

5. Division of Cardiovascular Medicine Brigham and Women's Hospital Harvard Medical School Boston Massachusetts

6. Department of Haematological Medicine Guy's and St Thomas’ Hospitals London UK

Funder

Portola Pharmaceuticals

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14600

Reference20 articles.

1. A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

2. Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

3. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

4. Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients

5. Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what’s new?;Blood Advances;2023-09-13

2. Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older;Journal of Thrombosis and Haemostasis;2021-08-17

3. Current Opinion on the use of Direct Oral Anticoagulants for the Prophylaxis of Venous Thromboembolism among Medical Inpatients;Therapeutics and Clinical Risk Management;2021-05

4. Provider perceptions of extended venous thromboembolism prophylaxis for hospitalized medically ill patients;Thrombosis Update;2021

5. Inpatient prophylaxis in cancer patients: where is the evidence?;Thrombosis Research;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3